Article · 2023
Editorial Board Member
Adel Gouri
Lecturer and Research scientist in College of Medicine, Badji Mokhtar University, Algeria
About
As published by the journal they serve.
Adel Gouri is a Medical laboratory manager at national Institute of Paramedical Education, Algeria. He has published lot of efficient research works and has won awards for his works. His reseach interest lies on Cancer biology and new markers of cancers, Atherosclerosis and lipoproteins metabolism, Hemodialysis and nephrology, Hematologic diseases. He has also presented his papers in many international and national conference.He hold membership over number of Journal boards.
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Hematology & Thromboembolic DiseasesEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2022
Brief Note on Epidemiology and Treatment of Venous Thromboembolism
Article · 2015
Molecular Monitoring of Chronic Myeloid Leukemia (CML): A Current Perspective
Article · 2015
Predictive Biomarkers of Thromboembolic Events in Cancer
Article · 2015
Urokinase Plasminogen Activator System and Hematologic Malignancies: Potential Role in Diagnosis and Therapy
Article · 2014
Proteasome Activity as New Approach to the Management of Multiple Myeloma
Article · 2014
New Insights into Diagnosis of Monoclonal Gammopathy of Undetermined Significance:Emerging Role of Micro RNAs
Article · 2014
Hematologic Malignancies Therapy and Cardiotoxicity: New Biomarkers
Article · 2014
Cereblon as a Predictive Biomarker for Imid Therapy Sensitivity
Article · 2013
Polycythemia Vera and Acute Coronary Syndromes: Pathogenesis, Risk Factors and Treatment
Article · 2022
Working Conditions and Health in MENA Region During the Covid-19 Pandemic: Keeping an Eye on The Gap.
Article · 2016
CDA-NABC-cytidine deaminase activity a predictive marker of toxicity/efficacy in nucleosidic analogs-based chemotherapy
Article · 2016
CDA-NABC-cytidine deaminase activity a predictive marker of toxicity/efficacy in nucleosidic analogs-based chemotherapy
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.